Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesThinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk
Vascular Health and Risk Management, 09/22/09
Some trials have highlighted the significance of residual cardiovascular risk after treatment of LDL–C to target levels. This residual risk is partially due to low HDL–C and high triglycerides (TG) despite achievement of LDL goals with statin therapy. The NCEP ATP III guidelines reported that low HDL–C is a significant and an independent risk factor for coronary heart disease (CHD) and is inversely related to CHD. Epidemiologic studies have also shown a similar inverse relationship of HDL–C with CHD. High–density lipoprotein cholesterol (HDL–C) may directly participate in the anti–atherogenic process by promoting efflux of cholesterol of the foam cells of atherogenic lesions. Many studies have demonstrated multiple anti–atherogenic actions of HDL–C and its role in promoting efflux of cholesterol from the foam cells. The residual risk by increased TG with or without low HDL–C can be assessed by calculating non–HDL–C and a reduction in TG results in decreased CHD.
Related Articles
Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
Expert Review of Cardiovascular Therapy, 11/16/09
Relevance Score: 99%
Reduction of Skeletal Muscle, Especially in Lower Limbs, in Japanese Type 2 Diabetic Patients With Insulin Resistance and Cardiovascular Risk Factors
Metabolic Syndrome and Related Disorders, 11/11/09
Relevance Score: 97%
The value of drugs for obesity in the management of cardiovascular risk factors
Sang Thrombose Vaisseaux, 11/04/09
Relevance Score: 97%
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
Vascular Health and Risk Management, 11/03/09
Relevance Score: 97%
Reference Values for 27 Clinical Chemistry Tests in 70-Year-Old Males and Females
Gerontology, 10/21/09
Relevance Score: 97%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
The High Prevalence of Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis Without Clinically Evident Cardiovascular Disease
Medicine, 11/20/09
Associations between Common Genetic Polymorphisms in Angiopoietin-Like Proteins 3 and 4 and Lipid Metabolism and Adiposity in European Adolescents and Adults
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia
Metabolism-Clinical and Experimental, 11/19/09
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Relationships of BMI to Cardiovascular Risk Factors Differ by Ethnicity
Obesity, 11/20/09
Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels
Diabetes Care, 11/20/09
Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes Study
Diabetes Care, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor